样式: 排序: IF: - GO 导出 标记为已读
-
From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-03-18
Abstract Introduction The COVID-19 pandemic exacerbated healthcare needs and caused excess mortality, especially among lower socioeconomic groups. This study describes the emergence of socioeconomic differences along the COVID-19 pathway of testing, healthcare use and mortality in the Netherlands. Methodology This retrospective observational Dutch population-based study combined individual-level registry
-
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-03-14 Micha J. Pilz, Simon Seyringer, Lára R. Hallsson, Andrew Bottomley, Femke Jansen, Madeleine T. King, Richard Norman, Marianne J. Rutten, Irma M. Verdonck-de Leeuw, Peter D. Siersema, Eva Maria Gamper
-
Economic value of diastasis repair with the use of mesh compared to no intervention in Italy Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-03-14 Carla Rognoni, Alessandro Carrara, Micaela Piccoli, Vincenzo Trapani, Nereo Vettoretto, Giorgio Soliani, Rosanna Tarricone
-
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-03-14 Simon van der Pol, Maarten J. Postma, Cornelis Boersma
-
The causal effect of early retirement on medication use across sex and occupation: evidence from Danish administrative data Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-03-13 Jolien Cremers, Torben Heien Nielsen, Claus Thorn Ekstrøm
-
Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-03-13 Timothée Lehut, Céline Lambert, Romain Mortier, Emmanuel Futier, Russell Chabanne, Ulrich Bauer, Philippe Verdier, Ramin Ravan, Philippe Ocquidant, Charline Mourgues, Alexandre Lautrette
Background Better cost-awareness is a prerogative in achieving the best benefit/risk/cost ratio in the care. We aimed to assess the cost-awareness of intensivists in their daily clinical practice and to identify factors associated with accurate estimate of cost (50–150% of the real cost). Methods We performed a prospective observational study in seven French ICUs. We compared the estimate of intensivists
-
What remains after the money ends? Evidence on whether admission reductions continued following the largest health and social care integration programme in England Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-03-09 Vasudha Wattal, Katherine Checkland, Matt Sutton, Marcello Morciano
-
Can redistribution of vaccine improve global welfare? Lessons from COVID-19 Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-29 Gunjan Kumari, Oindrila Dey
-
Preference-based utility weights for the Individualized Neuromuscular Quality of Life Questionnaire (INQoL), with a focus on non-dystrophic myotonia (NDM) Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-28 Andrew Lloyd, Kim Rand, Cleo Pike, Crispin Ellis
Introduction The Individualized Neuromuscular Quality of Life Questionnaire (INQoL) is used to measure quality of life in neuromuscular disorders such as non-dystrophic myotonia (NDM). Here we report methods to estimate utilities, with a focus on NDM, from this questionnaire based on two preference elicitation exercises. Methods Eight items from the INQoL were selected with input from three neuromuscular
-
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD) Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-27 Louis S. Matza, Katie D. Stewart, Marie Fournier, Donna Rowen, Robin Lachmann, Maurizio Scarpa, Eugen Mengel, Travis Obermeyer, Evren Ayik, Fernando Laredo, Ruth Pulikottil-Jacob
-
The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-27
Abstract Health authorities using cost-effectiveness analysis (CEA) for informing reimbursement decisions on health technologies increasingly require economic evaluations encompassing both CEA and budget impact analysis (BIA). Good Research Practices advocate that the economic and clinical assumptions underlying these analyses are aligned and consistently applied. Nonetheless, CEAs and BIAs often are
-
Systematic methodological review of health state values in glaucoma cost-utility analyses Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-27 Kevin Kennedy, Gurkaran Sarohia, Dominik Podbielski, Simon Pickard, Jean-Eric Tarride, Feng Xie
-
A principled approach to non-discrimination in cost-effectiveness Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-27 Darius N. Lakdawalla, Jason N. Doctor
-
Measuring EQ-5D-5L utility values in parents who have experienced perinatal death Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-25 Elizabeth M. Camacho, Katherine J. Gold, Margaret Murphy, Claire Storey, Alexander E. P. Heazell
-
Unravelling risk selection in Spanish general government employee mutual funds: evidence from cancer hospitalizations in the public health network Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-20 Jaime Pinilla, Beatriz G. López-Valcárcel, Enrique Bernal-Delgado
-
Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-14 Wenjing Zhou, Anle Shen, Zhihao Yang, Pei Wang, Bin Wu, Michael Herdman, Jan Busschbach, Nan Luo
The psychometric properties of the EQ-5D-Y have not been widely tested in severely ill children. The aim of this study was to assess and compare the validity and responsiveness of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric inpatients with haematological malignancies and caregivers. Respondents completed the interviewer-administered self-complete or proxy version of the EQ-5D-Y-3L and EQ-5D-Y-5L and
-
Comparing heuristic valuation processes between health state valuation from child and adult perspectives Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-03 Stefan A. Lipman, Vivian T. Reckers-Droog
-
A Spanish value set for the SF-6D based on the SF-12 v1 Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-02-01 Jorge-Eduardo Martínez-Pérez, José-María Abellán-Perpiñán, Fernando-Ignacio Sánchez-Martínez, Juan-José Ruiz-López
-
The Economic Costs of Informal Care: Estimates from a National Cross-Sectional Survey in The Netherlands Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-31 Saif Elayan, Viola Angelini, Erik Buskens, Alice de Boer
Faced with an unprecedented demand for long-term care, European health care systems are moving towards mixed care models, where the welfare state and informal caregivers share care responsibilities. While informal care is often viewed as a means of alleviating pressure on public care, it comes with significant economic costs for caregivers, their employers, and society at large. This study uses nationally
-
Pragmatic randomized controlled trial comparing a complex telemedicine-based intervention with usual care in patients with chronic conditions Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-31 Susanna Sten-Gahmberg, Kine Pedersen, Ingrid Gaarder Harsheim, Hanna Isabel Løyland, Øyvind Snilsberg, Tor Iversen, Geir Godager, Erik Magnus Sæther, Birgit Abelsen
-
Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-27 Andrea Marcellusi, Francesco Saverio Mennini, Massimo Andreoni, Loreta A. Kondili
-
AOTMiT reimbursement recommendations compared to other HTA agencies Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-23 Aneta Mela, Dorota Lis, Elżbieta Rdzanek, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Bartłomiej Drop, Tomasz Blicharski, Maciej Niewada
-
On spillovers in economic evaluations: definition, mapping review and research agenda Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-23 María J. Mendoza-Jiménez, Job van Exel, Werner Brouwer
-
A state-level analysis of macro-level factors associated with hospital readmissions Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-20 Reginald A. Silver, Joumana Haidar, Chandrika Johnson
-
Looking inside the lab: a systematic literature review of economic experiments in health service provision Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-11 Massimo Finocchiaro Castro, Calogero Guccio, Domenica Romeo
-
Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-09
Abstract Objective To estimate the cost-effectiveness of online behavioral interventions (EczemaCareOnline.org.uk) designed to support eczema self-care management for parents/carers and young people from an NHS perspective. Methods Two within-trial economic evaluations, using regression-based approaches, adjusting for baseline and pre-specified confounder variables, were undertaken alongside two independent
-
The impact of an ‘evergreening’ strategy nearing patent expiration on the uptake of biosimilars and public healthcare costs: a case study on the introduction of a second administration form of trastuzumab in The Netherlands Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-08
Abstract In this paper, we explore dynamic market share and public healthcare costs of trastuzumab’s evergreening (subcutaneous) variant during introduction of trastuzumab’s competitive biosimilar variants in the Netherlands. We used a time series design to assess dynamic market share of trastuzumab’s evergreening variant after introducing trastuzumab’s biosimilar variants, focusing on the number of
-
Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-05 J. P. Sevilla, Daniel Tortorice, David Kantor, John Regan, Kinga H. Meszaros, Ekkehard C. Beck, Najida Begum, David E. Bloom
-
Risk adjustment for regional healthcare funding allocations with ensemble methods: an empirical study and interpretation Eur. J. Health Econ. (IF 5.271) Pub Date : 2024-01-03 Tuukka Holster, Shaoxiong Ji, Pekka Marttinen
-
Impact of Long COVID on productivity and informal caregiving Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-12-26
Abstract Background Around 2 million people in the UK suffer from Long COVID (LC). Of concern is the disease impact on productivity and informal care burden. This study aimed to quantify and value productivity losses and informal care receipt in a sample of LC patients in the UK. Methods The target population comprised LC patients referred to LC specialist clinics. The questionnaires included a health
-
The elicitation of patient and physician preferences for calculating consumer-based composite measures on hospital report cards: results of two discrete choice experiments Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-12-15 Martin Emmert, Stefan Rohrbacher, Florian Meier, Laura Heppe, Cordula Drach, Anja Schindler, Uwe Sander, Christiane Patzelt, Cornelia Frömke, Oliver Schöffski, Michael Lauerer
-
Projected costs of informal care for older people in England Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-12-12 Bo Hu, Javiera Cartagena-Farias, Nicola Brimblecombe, Shari Jadoolal, Raphael Wittenberg
-
Patient-reported experience is associated with higher future revenue and lower costs of hospitals Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-12-09 Alice Giese, Rasheda Khanam, Son Nghiem, Thomas Rosemann, Michael M. Havranek
Background Despite the established positive association between patient experience and patient volume, the relationship between patient experience and the financial performance of hospitals has not been studied thoroughly. Methods To investigate this relationship, we used longitudinal data from 132 Swiss acute-care hospitals from 2016 to 2019 to examine the associations between patient experience and
-
Country-level effects of diagnosis-related groups: evidence from Germany’s comprehensive reform of hospital payments Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-12-05 Robert Messerle, Jonas Schreyögg
-
Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-11-17 Mario Cesare Nurchis, Francesca Clementina Radio, Luca Salmasi, Aurora Heidar Alizadeh, Gian Marco Raspolini, Gerardo Altamura, Marco Tartaglia, Bruno Dallapiccola, Gianfranco Damiani
-
Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-11-14 Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers, Tobias Boch, Julia Caroline Michaeli
-
Healthcare information management and operational cost performance: empirical evidence Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-11-11 Amit S. Malhan, Kiarash Sadeghi-R, Robert Pavur, Lou Pelton
-
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-11-02 Anna-Maria Fontrier, Bregtje Kamphuis, Panos Kanavos
-
Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-10-25 Maurizio Capuozzo, Venere Celotto, Andrea Zovi, Roberto Langella, Francesco Ferrara
-
The economic burden of mental disorders: results from the Netherlands mental health survey and incidence study-2 Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-10-24 B. F. M. Wijnen, M. Ten Have, R. de Graaf, H. J. van der Hoek, J. Lokkerbol, Filip Smit
Objective Currently, there is a paucity of up-to-date estimates of the economic burden caused by mental disorders. Such information could provide vital insight into one of the most serious and costly—yet to some extent preventable—health challenges facing the world today. Method Data from a national psychiatric-epidemiological cohort study (NEMESIS-2, N = 6506) were used to provide reliable, relevant
-
Pay-for-Performance incentives for specialised services in England: a mixed methods evaluation Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-10-13 Yan Feng, Søren Rud Kristensen, Paula Lorgelly, Rachel Meacock, Alberto Núñez-Elvira, Marina Rodés-Sánchez, Luigi Siciliani, Matt Sutton
-
Shaping a suitable EU HTA dossier template: why the German template is not fit for purpose Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-10-16 Maria Katharina Schweitzer, Manuel Nico Dold, Astrid Genet, Klaus Gossens, Thomas Klein-Hessling, Nils Löffler, Matthias Rabel, Andrej Rasch, Eva-Maria Reuter, Jessica Schmelcher, Natalia Wolfram, Sebastian Werner
From 2025, Health Technology Developers (HTDs) have to submit EU HTA dossiers. The joint clinical assessment (JCA) aims to streamline HTA processes and access to medicinal products across Europe. Currently, German HTA bodies IQWiG and G-BA actively shape the JCA methodology. Here we examine if German HTA dossier requirements are suitable for the JCA. We compare the number of safety endpoint and subgroup
-
How do family doctors respond to reduced waiting times for cancer diagnosis in secondary care? Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-10-03 Helen Hayes, Rachel Meacock, Jonathan Stokes, Matt Sutton
-
Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-09-27 Saskia Schawo, Renske Hoefman, Vivian Reckers-Droog, Liesbet Lawerman-van de Wetering, Yifrah Kaminer, Werner Brouwer, Leona Hakkaart-van Roijen
-
A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-09-20 Li Sun, Shruti Patel, Camilla Fiorina, Audrey Glass, Lise Rochaix, Anna M. Foss, Rosa Legood
-
Assessing the relation between financial performance and long-term bank loan interest rates for healthcare providers in the Netherlands: a panel data analysis Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-09-13 Erik Wackers, Rick Smit, Niek Stadhouders, Patrick Jeurissen
-
Modeling European health systems: a theoretical exercise. Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-09-04 L Garattini,Marco Badinella Martini
-
Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-09-01 Christian R. C. Kouakou, Jie He, Thomas G. Poder
-
Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-09-01 Lorna Wills, Diana Nagarwalla, Clare Pearson, Sean McPhail, Rose Hinchliffe, Ben Sharpless, Fahmina Fardus-Reid, Lyndsy Ambler, Samantha Harrison, Jon Shelton
-
The impacts of working from home on individual health and well-being Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-08-30 Manuel Denzer, Philipp Grunau
-
Length of hospital stays and financial incentives: evidence from Dutch rehabilitation centers Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-08-09 Katalin Gaspar, Ramsis Croes, Misja Mikkers, Xander Koolman
-
Using machine learning to estimate health spillover effects Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-08-06 Bruno Wichmann, Roberta Moreira Wichmann
-
Immigrant assimilation in health care utilisation in Spain Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-07-31 Zuleika Ferre, Patricia Triunfo, José-Ignacio Antón
-
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-07-24 Jeroen H. J. Paulissen, Ahmed H. Seddik, Kyle J. Dunton, Christopher J. Livings, Marinus van Hulst, Maarten J. Postma, Lisa A. de Jong, Roel D. Freriks
-
Disclosing the ‘Big C’: what does cancer survivorship signal to employers? Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-07-22 Philippe Sterkens, Adelina Sharipova, Stijn Baert
-
Scales and size-quality outcomes in adult learning disability residential care: evidence from the UK Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-07-19 Chelsea Chunwen Xiao, Nikita Makarchev, Xin Tao
-
Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-07-11 Jean-Baptiste Trouiller, Georgios F. Nikolaidis, Bérengère Macabeo, Nicolas Meyer, Laetitia Gerlier, Max Schlueter, Philippe Laramee
-
Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-07-11 Nicolas Boespflug, Jérôme Wittwer, Antoine Bénard
-
The effect of telephone health coaching and remote exercise monitoring for peripheral artery disease (TeGeCoach) on health care cost and utilization: results of a randomized controlled trial Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-07-10 Dirk Heider, Farhad Rezvani, Herbert Matschinger, Jörg Dirmaier, Martin Härter, Lutz Herbarth, Patrick Steinisch, Hannes Böbinger, Franziska Schuhmann, Gundula Krack, Thomas Korth, Lara Thomsen, Daniela Patricia Chase, Robert Schreiber, Mark-Dominik Alscher, Benjamin Finger, Hans-Helmut König
-
The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off Eur. J. Health Econ. (IF 5.271) Pub Date : 2023-07-08 Zhongyu Lang, Arthur E. Attema, Stefan A. Lipman